OnKure Therapeutics (OKUR) Non-Current Assets (2020 - 2026)
OnKure Therapeutics (OKUR) reported Non-Current Assets of $1.68 million for Q2 2026, up 10.4% from $1.52 million a year earlier and up 38.3% from the prior quarter.
Powered by 
Analysis
OnKure Therapeutics (OKUR) Non-Current Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, OnKure Therapeutics posted Non-Current Assets of $1.28 million, down 32.9% from FY2024.
- Non-Current Assets has a five-year compound annual growth rate of 45.5% (FY2020 to FY2025).
- By year, Non-Current Assets came in at $1.9 million in FY2024 (-3.3%), $1.97 million in FY2023 (+7.6%), $1.83 million in FY2022 (+530.7%) and $290,000 in FY2021 (+48.0%).
- The Q2 2026 figure ranks as the highest quarterly Non-Current Assets since Q1 2025.
- Year over year, Non-Current Assets gained in four of the last eight quarters, with growth averaging 29.6%.
- The high point for year-over-year Non-Current Assets in five years was Q2 2022 (growth of 879.8%); the low point was Q1 2024 (a decline of 61.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.21 million (Q1 2026), $1.28 million (Q4 2025) and $1.31 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 159.77 Bn |
| 10 | OnKure Therapeutics | 112.21 Mn | -385.72 Mn | - | 1.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.68 Mn |
| Mar 31, 2026 | 1.21 Mn |
| Dec 31, 2025 | 1.28 Mn |
| Sep 30, 2025 | 1.31 Mn |
| Jun 30, 2025 | 1.52 Mn |
| Mar 31, 2025 | 1.71 Mn |
| Dec 31, 2024 | 1.90 Mn |
| Sep 30, 2024 | 646,000.00 |
| Jun 30, 2024 | 727,000.00 |
| Mar 31, 2024 | 712,000.00 |
| Dec 31, 2023 | 1.97 Mn |
| Sep 30, 2023 | 1.62 Mn |
| Jun 30, 2023 | 1.72 Mn |
| Mar 31, 2023 | 1.85 Mn |
| Dec 31, 2022 | 1.83 Mn |
| Sep 30, 2022 | 1.51 Mn |
| Jun 30, 2022 | 1.60 Mn |
| Mar 31, 2022 | 1.70 Mn |
| Dec 31, 2021 | 290,000.00 |
| Sep 30, 2021 | 278,000.00 |
API Access
OnKure Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=OKUR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "OKUR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=OKUR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();